Literature DB >> 34115261

CXCL2-CXCR2 axis mediates αV integrin-dependent peritoneal metastasis of colon cancer cells.

Mattias Lepsenyi1, Nader Algethami1, Amr A Al-Haidari1, Anwar Algaber1, Ingvar Syk1, Milladur Rahman1, Henrik Thorlacius2.   

Abstract

Peritoneal metastasis is an insidious aspect of colorectal cancer. The aim of the present study was to define mechanisms regulating colon cancer cell adhesion and spread to peritoneal wounds after abdominal surgery. Mice was laparotomized and injected intraperitoneally with CT-26 colon carcinoma cells and metastatic noduli in the peritoneal cavity was quantified after treatment with a CXCR2 antagonist or integrin-αV-antibody. CT-26 cells expressed cell surface chemokine receptors CXCR2, CXCR3, CXCR4 and CXCR5. Stimulation with the CXCR2 ligand, CXCL2, dose-dependently increased proliferation and migration of CT-26 cells in vitro. The CXCR2 antagonist, SB225002, dose-dependently decreased CXCL2-induced proliferation and migration of colon cancer cells in vitro. Intraperitoneal administration of CT-26 colon cancer cells resulted in wide-spread growth of metastatic nodules at the peritoneal surface of laparotomized animals. Laparotomy increased gene expression of CXCL2 at the incisional line. Pretreatment with CXCR2 antagonist reduced metastatic nodules by 70%. Moreover, stimulation with CXCL2 increased CT-26 cell adhesion to extracellular matrix (ECM) proteins in a CXCR2-dependent manner. CT-26 cells expressed the αV, β1 and β3 integrin subunits and immunoneutralization of αV abolished CXCL2-triggered adhesion of CT-26 to vitronectin, fibronectin and fibrinogen. Finally, inhibition of the αV integrin significantly attenuated the number of carcinomatosis nodules by 69% in laparotomized mice. These results were validated by use of the human colon cancer cell line HT-29 in vitro. Our data show that colon cancer cell adhesion and growth on peritoneal wound sites is mediated by a CXCL2-CXCR2 signaling axis and αV integrin-dependent adhesion to ECM proteins.

Entities:  

Keywords:  Chemokines; Chemotaxis; Integrins; Metastasis; Peritoneal carcinomatosis

Year:  2021        PMID: 34115261     DOI: 10.1007/s10585-021-10103-0

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  39 in total

Review 1.  Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.

Authors:  Manuel J Koppe; Otto C Boerman; Wim J G Oyen; Robert P Bleichrodt
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

Review 2.  Chemokine receptors and their role in inflammation and infectious diseases.

Authors:  C Murdoch; A Finn
Journal:  Blood       Date:  2000-05-15       Impact factor: 22.113

3.  Individualized prediction of risk of metachronous peritoneal carcinomatosis from colorectal cancer.

Authors:  J Segelman; O Akre; U O Gustafsson; M Bottai; A Martling
Journal:  Colorectal Dis       Date:  2014-05       Impact factor: 3.788

4.  Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis.

Authors:  Jan Franko; Zuhaib Ibrahim; Niraj J Gusani; Matthew P Holtzman; David L Bartlett; Herbert J Zeh
Journal:  Cancer       Date:  2010-08-15       Impact factor: 6.860

Review 5.  Chemokines in cancer.

Authors:  Alain P Vicari; Christophe Caux
Journal:  Cytokine Growth Factor Rev       Date:  2002-04       Impact factor: 7.638

Review 6.  The chemokine system in cancer biology and therapy.

Authors:  Alberto Mantovani; Benedetta Savino; Massimo Locati; Luca Zammataro; Paola Allavena; Raffaella Bonecchi
Journal:  Cytokine Growth Factor Rev       Date:  2009-12-08       Impact factor: 7.638

7.  Peritoneal carcinomatosis from colorectal cancer.

Authors:  D G Jayne; S Fook; C Loi; F Seow-Choen
Journal:  Br J Surg       Date:  2002-12       Impact factor: 6.939

Review 8.  Update on the prevention of local recurrence and peritoneal metastases in patients with colorectal cancer.

Authors:  Paul H Sugarbaker
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

9.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

10.  Cytoreduction and HIPEC in the Netherlands: nationwide long-term outcome following the Dutch protocol.

Authors:  Anke M J Kuijpers; Boj Mirck; Arend G J Aalbers; Simon W Nienhuijs; Ignace H J T de Hingh; Martinus J Wiezer; Bert van Ramshorst; Robert J van Ginkel; Klaas Havenga; Andreas J Bremers; Johannes H W de Wilt; Elisabeth A Te Velde; Vic J Verwaal
Journal:  Ann Surg Oncol       Date:  2013-07-30       Impact factor: 5.344

View more
  6 in total

Review 1.  Role of chemokine systems in cancer and inflammatory diseases.

Authors:  Hongyi Li; Min Wu; Xia Zhao
Journal:  MedComm (2020)       Date:  2022-06-08

2.  Yin Yang 1 regulates ITGAV and ITGB1, contributing to improved prognosis of colorectal cancer.

Authors:  Nami Sato; Nozomu Sakai; Katsunori Furukawa; Tsukasa Takayashiki; Satoshi Kuboki; Shigetsugu Takano; Gaku Ohira; Hisahiro Matsubara; Masayuki Ohtsuka
Journal:  Oncol Rep       Date:  2022-03-10       Impact factor: 3.906

3.  Sensory neuron dysfunction in orthotopic mouse models of colon cancer.

Authors:  Mihály Balogh; Jixiang Zhang; Caitlyn M Gaffney; Neha Kalakuntla; Nicholas T Nguyen; Ronnie T Trinh; Clarissa Aguilar; Hoang Vu Pham; Bojana Milutinovic; James M Nichols; Rajasekaran Mahalingam; Andrew J Shepherd
Journal:  J Neuroinflammation       Date:  2022-08-12       Impact factor: 9.587

Review 4.  Tumor-Associated Neutrophils in Colorectal Cancer Development, Progression and Immunotherapy.

Authors:  Wei Zheng; Jingjing Wu; Yao Peng; Jing Sun; Pu Cheng; Qi Huang
Journal:  Cancers (Basel)       Date:  2022-09-29       Impact factor: 6.575

Review 5.  Neutrophil Extracellular Traps in Colorectal Cancer Progression and Metastasis.

Authors:  Umama Khan; Sabrina Chowdhury; Md Morsaline Billah; Kazi Mohammed Didarul Islam; Henrik Thorlacius; Milladur Rahman
Journal:  Int J Mol Sci       Date:  2021-07-06       Impact factor: 5.923

6.  Impacts of Chemokine (C-X-C Motif) Receptor 2 C1208T Polymorphism on Cancer Susceptibility.

Authors:  Jing Zhou; Hao Wu; Quan-Xin Su; Xiao-Kai Shi; Bo-Wen Tang; Cui-Ping Zhao; Hai Wang; Xiao-Ping Chen
Journal:  J Immunol Res       Date:  2021-10-14       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.